Lignocaine hydrochloride (400 mg) was given orally to 12 patients prior to anaesthesia for laparoscopy. Serial blood samples were taken for estimation of plasma lignocaine concentrations. The results were compared with those obtained from 7 conscious healthy volunteers who took lignocaine alone. There was a marked delay in the rise of plasma concentrations of lignocaine in the anaesthetized patients indicating delayed absorption. In these patients the drug disappeared from the plasma much more slowly, suggesting impaired metabolism of lignocaine. This effect could not be attributed to halothane.
Lignocaine hydrochloride (400 mg) was given orally to 12 patients prior to anaesthesia for laparoscopy. Serial blood samples were taken for estimation of plasma lignocaine concentrations. The results were compared with those obtained from 7 conscious healthy volunteers who took lignocaine alone. There was a marked delay in the rise of plasma concentrations of lignocaine in the anaesthetized patients indicating delayed absorption. In these patients the drug disappeared from the plasma much more slowly, suggesting impaired metabolism of lignocaine. This effect could not be attributed to halothane.
Very little is known of the effects of anaesthesia on the absorption, distribution and metabolism of drugs. If anaesthetic agents cause impairment of liver function, the effects of many lipid soluble drugs are likely to be exaggerated and prolonged since these compounds are usually inactivated by metabolism in the liver (Brodie, 1964; Prescott, 1972) '. Such effects could be of particular significance in view of the alleged hepatotoxicity of halogenated hydrocarbons such as halothane and chloroform.
In the course of an investigation into the use of oral lignocaine in the prophylaxis of ventricular arrhythmias occurring during laparoscopy, serial plasma concentrations of lignocaine were determined and found to differ considerably from those seen in normal conscious subjects. The results of these studies are presented below.
METHODS

Patients.
Twelve healthy patients aged between 22 and 39 years scheduled for laparoscopy and tubal diathermy volunteered for the study. Except for 5 patients on oral contraceptives, none of the patients was taking drugs regularly and none had clinical evidence of hepatic, cardiac, renal or gastrointestinal disease.
Procedure.
After an overnight fast each patient ingested 400 mg of lignocaine hydrochloride as tablets (equivalent to 346 mg lignocaine base) with 40 ml of water 0.5 to 2 hr before induction of anaesthesia. Venous blood was sampled at frequent intervals for 12 hr through an indwelling cannula.
Premedication consisted solely of atropine sulphate 0.6 mg given intramuscularly 1 hr preoperatively. Induction was carried out with thiopentone 400 mg intravenously. In 6 patients gallamine 60 mg was given and anaesthesia was maintained with halothane 2% and a mixture of nitrous oxide (3 L/min) and oxygen (1 l./min) in a semiclosed system incorporating a carbon dioxide absorber. Respiration was spontaneous throughout. The other 6 patients received gallamine 80 mg, halothane was omitted, and respiration was controlled using intermittent positive pressure.
The duration of anaesthesia varied from 8 to 15 min. Carbon dioxide insufflation was used for the laparoscopy and the duration of peritoneal inflation was 4-5 min. There were no operative complications. All patients were ambulant 3 hr after laparoscopy and were discharged home the following day.
Controls.
Control studies were carried out in 7 fasting unanaesthetized healthy volunteers (4 males, 3 females) aged between 22 and 37. They received oral lignocaine only as described above.
Plasma lignocaine.
Plasma was stored at -20°C until the time of analysis. Lignocaine was estimated in plasma using the specific gas-liquid chromatographic method of Keeneghan (1968) as modified by Prescott and Nimmo (1971a) . A Hewlett-Packard Model 402 gasliquid chromatograph equipped with flame ionization detectors was used. The column was a glass U-tube, 4 ft long, i in. diameter, packed with 3% HI-EFF 8 BP on 80/100 mesh Gas Chrom Q. The nitrogen carrier gas flow was 60 ml/min and the oven was maintained at 210° C. The standard deviation of a single estimation of a sample containing 0.5 /ig lignocaine/ml is approximately 4% in this laboratory.
RESULTS
There were no consistent differences between the mean plasma lignocaine concentrations in the two anaesthetized groups of patients and their data have therefore been pooled for comparison with the control subjects (table I) .
Lignocaine absorption was much slower and the drug disappeared from the plasma more slowly in the patients than in the healthy volunteers (figs. 1 and 2). Thus the mean peak plasma lignocaine concentration occurred at 45 min in the healthy volunteers as compared with 3 hr in the patients. However, the mean of the individual peak plasma lignocaine concentrations were similar in volunteers and anaesthetized patients (table II) . The estimated mean plasma lignocaine half-life was 1.3 hr in control subjects and 2.8 hr in the patients. After 9 hr the half-life was prolonged to 4.8 hr in the patients undergoing laparoscopy.
Although mean plasma lignocaine concentrations were higher in healthy volunteers up to 2 hr, the 
Number of observations are given in parentheses. 
HOURS
concentrations were much higher in the patients at all times after 2 hr (table II and figs. 1 and 2). For example, at 6 hr the mean plasma lignocaine concentration in laparoscopy patients was more than five times higher than that in healthy volunteers (table n and fig. 2 ).
DISCUSSION
The plasma concentration of lignocaine at any given time is determined by the relative rates of absorption, distribution and elimination. The present findings indicate that the absorption and elimination of lignocaine are significantly delayed in patients undergoing laparoscopy. The abnormally slow absorption in the patients could have been caused by decreased gastrointestinal motility, delayed gastric emptying (Prescott and Nimmo, 1971b) or reduction in splanchnic blood flow. These factors may be affected by nervous tension in unsedated patients prior to surgery. In addition we have shown that atropine alone slows absorption of oral lignocaine in manpresumably by delaying gastric emptying (AdjeponYamoah, Prescott and Scott, unpublished). Insufflation of the peritoneum with carbon dioxide during laparoscopy is unlikely to have had a major effect since absorption was delayed long after the end of the procedure. Since negligible amounts of lignocaine are excreted unchanged in the urine, the higher plasma lignocaine concentrations after 3 hr and the longer lignocaine half-life in the patients can probably be attributed to decreased hepatic lignocaine metabolism. A number of factors might alter liver function and thus contribute to the reduced hepatic metabolism of lignocaine. Hepatic blood flow can be a major determinant of the disposition of metabolized drugs (Whitsett, Dayton and McNay, 1971) and Shackman, Graber and Melrose (1953) found a 30% decrease in hepatic blood flow and decreased hepatic and splanchnic oxygen consumption in anaesthetized subjects. Furthermore, liver metabolism is impaired by hypoxia and this might also render the liver more susceptible to potentially hepatotoxic agents. There is no significant change in cardiac output during laparoscopy (Marshall et al., 1972) , but the hepatic clearance of lignocaine could be reduced through regional haemodynamic changes associated with increased intra-abdominal pressure.
Hypercarbia is another possible contributory factor. Morris and Feldman (1963) found that the postoperative retention of bromsulphthalein (BSP) was increased by hypercarbia during halothane anaes-tbcsia. Retention of carbon dioxide undoubtedly occurred in the laparoscopy patients since the mean Pco 2 rose from 43.2 to 60.8 mm Hg in other patients undergoing the same procedure (Scott and Julian, 1972) .
Because the plasma lignocaine concentrations were similar in the two groups of patients, hepatotoxicity due to halothane can probably be excluded as a cause of the prolonged lignocaine half-life. Alternatively, it could be postulated that nitrous oxide and halothane are equally toxic to the liver.
Thiopentone, halothane and lignocaine are metabolized by hepatic drug metabolizing enzymes and the drug with the greatest affinity for the enzymes would be metabolized in preference to those with lower affinity. Acute administration of some microsomal inducing agents can cause an initial inhibition of drug metabolism (Kato, Chiesara and Vassenelli, 1964) . Thiopentone could perhaps interfere with lignocaine metabolism by this mechanism.
The changes observed in the present study occurred after short periods of anaesthesia in patients with no complicating pathology. The ability of the liver to metabolize different drugs during longer periods of anaesthesia is not known, but Karlin and Kutt (1970) described diphenylhydantoin intoxication in an epileptic patient after halothane anaesthesia. For reasons which are obscure, these workers attributed this effect to impaired diphenylhydantoin metabolism due to halothane hepatotoxicity.
Delayed gastrointestinal absorption following anaesthesia is of little consequence, but impaired hepatic drug metabolism could be very important clinically.
ABSORPTION ET METABOLISME ALTERES DE LIGNOCAINE PAR VOIE ORALE CHEZ DES PATIENTS SUBISSANT UNE LAPAROSCOPIE
SOMMAIRE 400 mg dTiydrochlorure ont M administres par voie orale a douze patients avant l'anesthe'sie pour laparoscopie. Des echantillons sanguins ont iti preteves en s£rie pour estimer les concentrations plasmatiques de lignocaine. Les resultats obtenus ont iti compares avec ceux obtenus chez sept volontaires sains conscients, recevant lignocaine seule. II y eut un retard marqui de raugmentation des concentrations plasmatiques de lignocaine chez les patients anesthesies, indiquant une absorption retardee. Le medicament s'elimina beaucoup plus lentement du plasma chez ces patients, sugglrant un mitabolisme alteri de lignocaine. Cet effet n'a pas pu etre attribu6 a l'halothane. Pp. 261; indexed; illustrated. It is a relief to see that something so basic to anaesthesia as the care of the airway is not only still being taught vigorously and correctly, but that modern textbooks reiterating what is at the very heart of clinical anaesthesia are still being written. This book is the work of a group of seven "practising anesthesiologists" and one e.n.L surgeon, all from Ontario, Canada. It brings the clinical subject of airway control up to date in the context of modern anaesthetic knowledge and practice. The relevant anatomical and physiological features of the pharynx and larynx are discussed from a clinical standpoint in the first section. Then follow essays on various problems concerned with the anaesthetic management of adults and children with airway problems, particularly when these occur in the intensive care unit. Three of the eight chapters deal with the peculiar problems of tracheostomy, one of them being written from a surgical point of view. This is a useful book in the Clinics series, which will be read with profit by every young anaesthetist (and by some older ones too). The style of writing is attractive, the illustrations clear and helpful, the references relevant and not too many, and the text is well illuminated with case reports so that the reader is in no doubt about the fundamental importance and overriding priority which must be given to the maintenance of a clear airway.
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